AUA Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

AUA Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,500	Closed	-$10K	–	186
2019 Q3	$10K	Hold	1,500	–	–	0.01%	162
2019 Q2	$14K	Hold	1,500	–	–	0.01%	151
2019 Q1	$24K	Hold	1,500	–	–	0.02%	131
2018 Q4	$23K	Hold	1,500	–	–	0.02%	130
2018 Q3	$32K	Hold	1,500	–	–	0.03%	128
2018 Q2	$36K	Hold	1,500	–	–	0.03%	129
2018 Q1	$26K	Hold	1,500	–	–	0.02%	137
2017 Q4	$28K	Hold	1,500	–	–	0.03%	136
2017 Q3	$26K	Hold	1,500	–	–	0.02%	136
2017 Q2	$50K	Hold	1,500	–	–	0.04%	124
2017 Q1	$48K	Hold	1,500	–	–	0.05%	102
2016 Q4	$54K	Buy	+1,500	New	+$59.9K	0.05%	117

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

AUA Capital Management's TEVA Position: Q4 2019 in Review

AUA Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 1,500 shares — an estimated $10K sold.

AUA Capital Management first reported a position in TEVA in Q4 2016 and held it in 12 quarters. The position peaked at $54K in Q4 2016. 436 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

AUA Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
AUA Capital Management sold 1,500 Teva Pharmaceuticals shares in Q4 2019, an estimated $10K.
AUA Capital Management first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 12 quarters.
AUA Capital Management's Teva Pharmaceuticals position peaked at $54K in Q4 2016.
436 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on AUA Capital Management's 13F filing for Q4 2019, filed 10 Jan 2020.